How does stem cell therapy help Crohn's disease?

MSCs reduce intestinal inflammation, promote mucosal healing, modulate the overactive immune response driving Crohn's, and help repair fistulae. Clinical studies show significant improvements in Crohn's Disease Activity Index scores after MSC therapy.

Can stem cell therapy heal Crohn's fistulae?

Yes. MSC therapy has shown remarkable success in healing perianal and enterocutaneous fistulae in Crohn's patients. The EU-approved Alofisel (darvadstrocel) is an MSC-based therapy specifically for Crohn's fistulae, validating this approach.

What improvements can Crohn's patients expect?

Patients commonly report reduced abdominal pain, less frequent bowel movements, improved appetite, weight stabilization, reduced steroid dependency, and significantly improved quality of life within 1-3 months of treatment.

Is stem cell therapy safe for Crohn's disease?

Yes. MSC therapy has been extensively studied in IBD patients with an excellent safety profile. The anti-inflammatory and tissue-repair properties of MSCs make them particularly well-suited for treating intestinal inflammation.

Crohn's Disease Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for Crohn's disease. MSC treatments reduce intestinal inflammation, promote mucosal healing, modulate the immune response, and help heal fistulae. EU-validated approach with proven clinical efficacy.

About Crohns Disease Stem Cell Therapy in Istanbul

Stem cell therapy for Crohn's disease at StemCell Longevita in Istanbul reduces intestinal inflammation, promotes mucosal healing, and modulates the immune dysfunction driving this chronic inflammatory bowel condition. Our MSC treatments — validated by the EU-approved MSC therapy Alofisel — offer a scientifically-proven regenerative approach.

How Stem Cell Therapy Works for This Condition

Crohn's involves transmural intestinal inflammation driven by an overactive mucosal immune response. MSCs suppress the Th1/Th17 inflammatory pathways driving Crohn's, promote intestinal epithelial regeneration and mucosal barrier repair, reduce pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6), and heal fistulae through direct tissue repair and anti-inflammatory action. The EU approval of the MSC-based therapy Alofisel for Crohn's fistulae validates the efficacy of this approach.

Who Is a Candidate?

Patients with moderate-to-severe Crohn's disease, perianal or enterocutaneous fistulae, biologic therapy failure, and those seeking to reduce immunosuppressive medication burden. MSC therapy can complement existing treatment regimens.

Treatment Process at StemCell Longevita

After review of colonoscopy findings, inflammatory markers (calprotectin, CRP), and imaging (MRI enterography), treatment involves systemic IV MSC infusion. For perianal fistulae, local injection of MSCs may be added for direct fistula healing.

Expected Results & Recovery

Reduced CDAI scores, improved stool patterns, decreased abdominal pain, reduced fistula drainage and healing, and improved quality of life within 1-3 months. Endoscopic improvement may be visible at follow-up colonoscopy.

Why Choose Turkey for Treatment?

Istanbul's gastroenterology centers provide comprehensive IBD evaluation. MSC therapy for Crohn's at 60-80% lower cost than Western biologic therapy, with the added potential of fistula healing.

Cost of Treatment

Crohn's disease stem cell therapy from €6,950, including GI assessment, MSC infusion, hotel, transfers, and 12-month follow-up.

Part of Our Autoimmune Diseases Treatment Cluster

Autoimmune Diseases — Treatment Cluster

Pillar: MSC treatment for autoimmune diseases in Turkey

Research & guides: how MSC therapy modulates the immune system | stem cell therapy for autoimmune diseases in Istanbul

Frequently Asked Questions About Crohn's Disease Stem Cell Therapy

How does stem cell therapy help Crohn's disease?: MSCs reduce intestinal inflammation, promote mucosal healing, modulate the overactive immune response driving Crohn's, and help repair fistulae. Clinical studies show significant improvements in Crohn's Disease Activity Index scores after MSC therapy.
Can stem cell therapy heal Crohn's fistulae?: Yes. MSC therapy has shown remarkable success in healing perianal and enterocutaneous fistulae in Crohn's patients. The EU-approved Alofisel (darvadstrocel) is an MSC-based therapy specifically for Crohn's fistulae, validating this approach.
What improvements can Crohn's patients expect?: Patients commonly report reduced abdominal pain, less frequent bowel movements, improved appetite, weight stabilization, reduced steroid dependency, and significantly improved quality of life within 1-3 months of treatment.
Is stem cell therapy safe for Crohn's disease?: Yes. MSC therapy has been extensively studied in IBD patients with an excellent safety profile. The anti-inflammatory and tissue-repair properties of MSCs make them particularly well-suited for treating intestinal inflammation.